Results 171 to 180 of about 1,609,713 (317)
Cooperative Energy-Efficient Routing Protocol for Underwater Wireless Sensor Networks. [PDF]
Ahmad I +5 more
europepmc +1 more source
Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo +88 more
wiley +1 more source
Socially-Aware Adaptive Delay Tolerant Network (DTN) routing protocol. [PDF]
Ullah S, Qayyum A.
europepmc +1 more source
Cognitive Behavioral Therapy for Youth With Childhood‐Onset Lupus: A Randomized Clinical Trial
Objective Our objective was to determine the feasibility and acceptability of the Treatment and Education Approach for Childhood‐Onset Lupus (TEACH), a six‐session cognitive behavioral intervention addressing depressive, fatigue, and pain symptoms, delivered remotely to individual youth with lupus by a trained interventionist.
Natoshia R. Cunningham +29 more
wiley +1 more source
VEER: a void-aware energy efficient routing algorithm for underwater wireless sensor networks. [PDF]
Khan G, Gola KK, Ali W, Gupta GK.
europepmc +1 more source
Environment and economic analysis of reverse supply chain scenarios for remanufacturing using discrete-event simulation approach. [PDF]
Ravichandran M +5 more
europepmc +1 more source
Objective We developed a novel electronic health record sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk +16 more
wiley +1 more source
DNS-Sensor: A Sensor-Driven Architecture for Real-Time DNS Cache Poisoning Detection and Mitigation. [PDF]
Yu H +5 more
europepmc +1 more source
The Freight Forwarder and the Development of Air Freight [PDF]
Emery, John C.
core +1 more source
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie +3 more
wiley +1 more source

